Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Place of perineal electrophysiologic testing in multiple sclerosis patients.
Possible clinical outcome measures for clinical trials in patients with multiple sclerosis.
Are human endogenous retroviruses triggers of autoimmune diseases? Unveiling associations of three diseases and viral loci.
Transglutaminase 2 and neuroinflammation.
Tadeusz Markiewicz - the researcher's profile and his role in the studies on neuromyelitis optica.
A case of acute combined central and peripheral demyelination.
Acute disseminated encephalomyelitis presenting as pyrexia of unknown origin.
Second-Line Therapy with Fingolimod for Relapsing-Remitting Multiple Sclerosis in Clinical Practice: The Effect of Previous Exposure to Natalizumab.
Multicenter measurements of myelin water fraction and geometric mean T2 : Intra- and intersite reproducibility.
TET2 gene expression and 5-hydroxymethylcytosine level in multiple sclerosis peripheral blood cells.
Randomized controlled trial of physical activity, cognition, and walking in multiple sclerosis.
Integrin-based therapeutics: biological basis, clinical use and new drugs.
How do immune cells support and shape the brain in health, disease, and aging?
Treatment of pediatric multiple sclerosis.
Mobilization of progenitors in the subventricular zone to undergo oligodendrogenesis in the Theiler's virus model of multiple sclerosis: Implications for remyelination at lesions sites.
Features of neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies.
Oligodendrocytes engineered with migratory proteins as effective graft source for cell transplantation in multiple sclerosis.
Antibody index test may aid PML diagnosis on natalizumab
Structural MRI substrates of cognitive impairment in neuromyelitis optica.
Olfactory System and Demyelination.
Detailing intra-lesional venous lumen shrinking in multiple sclerosis investigated by sFLAIR MRI at 7-T.
Magnetic resonance imaging in neuromyelitis optica.
Extracellular Vesicles in Multiple Sclerosis: What are They Telling Us?
Hypomethylating Agent 5-Aza-2'-deoxycytidine (DAC) Ameliorates Multiple Sclerosis in Mouse Models.
Cyclosporine in the treatment of a case of fulminant and refractory acute disseminated encephalomyelitis.

Pages